Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A
Open Access
- 1 May 2013
- journal article
- research article
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 27 (9), 1032-1045
- https://doi.org/10.1101/gad.212548.112
Abstract
To identify key regulators of human brain tumor maintenance and initiation, we performed multiple genome-wide RNAi screens in patient-derived glioblastoma multiforme (GBM) stem cells (GSCs). These screens identified the plant homeodomain (PHD)-finger domain protein PHF5A as differentially required for GSC expansion, as compared with untransformed neural stem cells (NSCs) and fibroblasts. Given PHF5A's known involvement in facilitating interactions between the U2 snRNP complex and ATP-dependent helicases, we examined cancer-specific roles in RNA splicing. We found that in GSCs, but not untransformed controls, PHF5A facilitates recognition of exons with unusual C-rich 3′ splice sites in thousands of essential genes. PHF5A knockdown in GSCs, but not untransformed NSCs, astrocytes, or fibroblasts, inhibited splicing of these genes, leading to cell cycle arrest and loss of viability. Notably, pharmacologic inhibition of U2 snRNP activity phenocopied PHF5A knockdown in GSCs and also in NSCs or fibroblasts overexpressing MYC. Furthermore, PHF5A inhibition compromised GSC tumor formation in vivo and inhibited growth of established GBM patient-derived xenograft tumors. Our results demonstrate a novel viability requirement for PHF5A to maintain proper exon recognition in brain tumor-initiating cells and may provide new inroads for novel anti-GBM therapeutic strategies.Keywords
This publication has 60 references indexed in Scilit:
- Oncogenic Splicing Factor SRSF1 Is a Critical Transcriptional Target of MYCCell Reports, 2012
- DEGRADE, MOVE, REGROUP: signaling control of splicing proteinsTrends in Biochemical Sciences, 2011
- Sudemycins, Novel Small Molecule Analogues of FR901464, Induce Alternative Gene SplicingACS Chemical Biology, 2011
- Synthetic mRNA Splicing Modulator Compounds with in Vivo Antitumor ActivityJournal of Medicinal Chemistry, 2009
- A Genome-wide siRNA Screen Reveals Diverse Cellular Processes and Pathways that Mediate Genome StabilityMolecular Cell, 2009
- A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras OncogeneCell, 2009
- Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumorsJournal of Neuro-Oncology, 2009
- Antitumor Compounds Based on a Natural Product Consensus PharmacophoreJournal of Medicinal Chemistry, 2008
- Glioma Stem Cells: A Midterm ExamNeuron, 2008
- A resource for large-scale RNA-interference-based screens in mammalsNature, 2004